MiNK Therapeutics, Inc. (INKT) insider trading.
In Q3 2026, insiders at MiNK Therapeutics, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Corvese Brian | Director | 1 | 0 | 0 |
| Ryan Barbara | Director | 1 | 0 | 0 |
| Behner Peter | Director | 1 | 0 | 0 |
| Holcomb John Bradley | Director | 1 | 0 | 0 |
| Wiinberg Ulf | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-01 | Corvese Brian | A (A) | 1,633 | $10.95 | 54,770 | Form 4 |
| 2026-09-01 | Ryan Barbara | A (A) | 1,622 | $10.95 | 23,591 | Form 4 |
| 2026-09-01 | Behner Peter | A (A) | 1,485 | $10.95 | 24,404 | Form 4 |
| 2026-09-01 | Holcomb John Bradley | A (A) | 1,233 | $10.95 | 4,691 | Form 4 |
| 2026-09-01 | Wiinberg Ulf | A (A) | 1,279 | $10.95 | 23,929 | Form 4 |
Transaction codes in this quarter
Get INKT insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1840229&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · INKT company page · MiNK Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling MiNK Therapeutics, Inc. (INKT)?
In Q3 2026, insiders at MiNK Therapeutics, Inc. reported 5 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these MiNK Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/inkt.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.